Compared to Estimates, AbbVie (ABBV) Q3 Earnings: A Look at Key Metrics

For the quarter ended September 2024, AbbVie (ABBV) reported revenue of $14.46 billion, up 3.8% over the same period last year. EPS came in at $3.00, compared to $2.95 in the year-ago quarter.The reported revenue represents a surprise of +1.29% over the Zacks Consensus Estimate of $14.28 billion. With the consensus EPS estimate being $2.92, the EPS surprise was +2.74%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their ...